BOLTON SECURITIES CORPORATION’s Arcturus Therapeutics ARCT Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$2.36K	Buy	+223	New	+$3.54K	﹤0.01%	1706

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.5B AUM 50.54% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's ARCT Position: Q1 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Arcturus Therapeutics (ARCT) in Q1 2025: 223 shares worth $2.36K. The stake represents ﹤0.01% of the portfolio and ranks #1706 among its holdings.

146 funds tracked by Wall St. Rank hold ARCT as of Q1 2025.

BOLTON SECURITIES CORPORATION held 223 shares of Arcturus Therapeutics worth $2.36K as of Q1 2025.
Arcturus Therapeutics was a new BOLTON SECURITIES CORPORATION position in Q1 2025.
Arcturus Therapeutics made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2025, its #1706 holding.
146 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2025, filed 12 Nov 2026.